Charles River Laboratories International, Inc. (NYSE: CRL) has announced a partnership with the American Heart Association, a leading nonprofit organization focused on heart and brain health. This collaboration aims to enhance awareness and prevention of cardiovascular disease through initiatives such as the Heart of Boston campaign, which seeks to improve health outcomes in Greater Boston and nationwide. Kristen Eisenhauer, Chief Commercial Officer of Charles River, emphasized the importance of supporting science-driven efforts to combat cardiovascular health issues. According to the American Heart Association's 2026 Heart Disease and Stroke Statistics Update, heart disease remains the leading cause of death in the United States, while stroke is the fourth-leading cause. Together, these conditions account for more than 25% of U.S. deaths, underscoring the need for continued education and research. The partnership aligns with Charles River's commitment to advancing human health beyond laboratory settings.